This review summarized the recent progress on Gd( iii )-based nanoparticles as T 1 -weighted MRI contrast agents and multimodal contrast agents.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: